Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis
Authors:
- 1 January 2009
- journal article
- Published by SAGE Publications in Lupus
- Vol. 18 (1) , 29-37
Abstract
Accumulating evidence indicates that interleukin (IL)-18 has a central role in the pathogenesis of lupus nephritis (LN). Although two recent studies showed that IL-18 promoter gene polymorphisms might be associated with systemic lupus erythematosus (SLE), to our knowledge, there have not been any reports concerning their association with LN. The aim of our study was to investigate the association of IL-18 promoter polymorphisms with World Health Organization pathological classes and identify their functional correlations. Sequence-specific primer polymerase chain reaction and the restriction fragment length polymorphism method were used to analyse the genotypes of IL-18 promoter polymorphism at the position −607 in 101 unrelated patients with LN, 64 non-renal patients with SLE and 174 ethnically matched healthy controls. Serum IL-18 levels were determined using enzyme-linked immunosorbent assay during the active phase. Immunohistochemical analysis was performed for IL-18 expression on renal biopsies from 72 patients with LN. Our results showed that patients with non-renal SLE had significantly higher frequencies of SNP−607/AA when compared to patients with LN (37.5% vs 18.8%, P < 0.05). LN patients with the AA genotype had significantly lower levels of serum IL-18 than those with the CA or CC genotype (P < 0.01) and also had lower levels of glomerular IL-18 expression than those with the CC genotype (P < 0.05). Significantly, higher frequencies of the SNP−607/AA genotype were observed in LN patients with WHO class III than in those with class IV (34.6% vs 15.6%, P < 0.05). The SNP−607/AA genotype was not observed in patients with LN who progressed to end-stage renal failure that required haemodialysis or renal transplantation. In conclusion, the SNP−607/AA genotype that had lower IL-18 levels might be a genetically protective factor against renal involvement in Chinese patients with SLE and against development of severe nephritis in patients with LN.Keywords
This publication has 32 references indexed in Scilit:
- British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosusArthritis & Rheumatism, 2007
- Intrarenal cytokine gene expression in lupus nephritisAnnals of the Rheumatic Diseases, 2007
- Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patientsGenes & Immunity, 2007
- Correlation of renal tubular epithelial cell–derived interleukin‐18 up‐regulation with disease activity in MRL‐Faslpr mice with autoimmune lupus nephritisArthritis & Rheumatism, 2002
- Genomic Organization and Regulation of the Human Interleukin-18 Gene. FRONTLINESScandinavian Journal of Immunology, 2000
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.Journal of Clinical Investigation, 1998
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Transition of Morphologic Features in Lupus Nephritis: Does Steroid Therapy Accelerate Glomerulosclerosis?Internal Medicine, 1995
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992